跳至主要内容
临床试验/NCT02061839
NCT02061839已完成不适用

Prevention of Melasma Relapse During Summertime

Centre de Pharmacologie Clinique Applique a la Dermatologie0 个研究点目标入组 40 人开始时间: 2013年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
主要终点
Comparison between MASI scores before prevention treatment and after 6 months

研究概览

简要总结

Main objective is to show that a photoprotective sunscreen having a protection against the visible light is more effective than a sunscreen having the same UVA AND UVB protection but with a low (weak) protection against the visible, to prevent the relapses of the melasma during the summertime.

详细描述

40 melasma affected women will be included and randomized in two parallel groups (one group protected by a UVA+UVB+visible extended sunscreen and one group group protected by a UVA+UVB sunscreen).

There will be 3 visits: Baseline, T2.5months and T5months (final visit).

Products application frequency: twice daily(morning and afternoon) and additional applications every 2 hours in case of solar exposure.

Main evaluation criterion: the MASI score assessed from standardized photographs (system VISIA, Canfield Scientific, USA) at Baseline, middle and end of study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Other pigmentary disorders associated (including PIH)

结局指标

主要结局

Comparison between MASI scores before prevention treatment and after 6 months

时间窗: 6 months

MASI scores are evaluated by two physicians blinded to the treatment received on standardized pictures taken before treatment and after 6 months of summer period

次要结局

未报告次要终点

研究者

发起方
Centre de Pharmacologie Clinique Applique a la Dermatologie
申办方类型
Other
责任方
Sponsor

相似试验